LU71223A1 - - Google Patents

Info

Publication number
LU71223A1
LU71223A1 LU71223A LU71223A LU71223A1 LU 71223 A1 LU71223 A1 LU 71223A1 LU 71223 A LU71223 A LU 71223A LU 71223 A LU71223 A LU 71223A LU 71223 A1 LU71223 A1 LU 71223A1
Authority
LU
Luxembourg
Application number
LU71223A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU71223A1 publication Critical patent/LU71223A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LU71223A 1973-11-03 1974-10-31 LU71223A1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2355094A DE2355094C3 (de) 1973-11-03 1973-11-03 Verfahren zur Herstellung eines Tetanus-Impfstoffs

Publications (1)

Publication Number Publication Date
LU71223A1 true LU71223A1 (enExample) 1976-08-19

Family

ID=5897187

Family Applications (1)

Application Number Title Priority Date Filing Date
LU71223A LU71223A1 (enExample) 1973-11-03 1974-10-31

Country Status (15)

Country Link
US (1) US4007265A (enExample)
JP (1) JPS5071820A (enExample)
AT (1) AT336784B (enExample)
AU (1) AU497398B2 (enExample)
BE (1) BE821833A (enExample)
CA (1) CA1038293A (enExample)
DE (1) DE2355094C3 (enExample)
DK (1) DK143383C (enExample)
FR (1) FR2249679B1 (enExample)
GB (1) GB1492596A (enExample)
IE (1) IE40098B1 (enExample)
IL (1) IL45960A (enExample)
IT (1) IT1043904B (enExample)
LU (1) LU71223A1 (enExample)
NL (1) NL7414114A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2510987C2 (de) 1974-10-29 1983-03-24 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanusimpfstoffes
DE2457047C3 (de) * 1974-12-03 1979-10-31 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe
US4200627A (en) 1976-07-31 1980-04-29 Behringwerke Aktiengesellschaft Atoxic, immunogenic product of tetanus toxin
US4264588A (en) * 1979-05-10 1981-04-28 The Charles River Breeding Laboratories, Inc. Vaccine for Clostridium perfringens type E enterotoxemia of rabbits
US4330623A (en) * 1980-02-19 1982-05-18 Merck & Co., Inc. Process for solubilization of gonococcal antigen
FR2498192A2 (fr) * 1981-01-22 1982-07-23 Pasteur Institut Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US5063162A (en) * 1987-04-24 1991-11-05 Hoffmann-La Roche Inc. Process for isolating nucleic acids utilizing protease digestion
DE3817724C2 (de) * 1988-05-25 1996-04-04 Siemens Ag Computertomograph
GB8914122D0 (en) * 1989-06-20 1989-08-09 Wellcome Found Polypeptide expression
US5601826A (en) * 1989-06-30 1997-02-11 The United States Of America As Represented By The Department Of Health And Human Services Peptide which produces protective immunity against tetanus
US5389540A (en) * 1989-11-28 1995-02-14 Evans Medical Limited Expression of tetanus toxin fragment C in yeast
JP4229341B2 (ja) 1996-03-23 2009-02-25 財団法人阪大微生物病研究会 破傷風毒素の機能的フラグメント抗原及び破傷風ワクチン

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617344B2 (de) * 1967-05-06 1976-04-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines tetanus-impfstoffes

Also Published As

Publication number Publication date
ATA876674A (de) 1976-09-15
FR2249679B1 (enExample) 1978-07-21
GB1492596A (en) 1977-11-23
DK143383B (da) 1981-08-17
BE821833A (fr) 1975-05-05
US4007265A (en) 1977-02-01
IL45960A (en) 1979-03-12
IT1043904B (it) 1980-02-29
DE2355094A1 (de) 1975-05-22
DE2355094B2 (de) 1978-10-05
DK571574A (enExample) 1975-06-23
CA1038293A (en) 1978-09-12
DK143383C (da) 1981-12-21
IE40098B1 (en) 1979-03-14
AT336784B (de) 1977-05-25
IE40098L (en) 1975-05-03
JPS5071820A (enExample) 1975-06-14
DE2355094C3 (de) 1979-05-23
FR2249679A1 (enExample) 1975-05-30
AU497398B2 (en) 1978-12-14
NL7414114A (nl) 1975-05-07
AU7490974A (en) 1976-05-06

Similar Documents

Publication Publication Date Title
AR201758A1 (enExample)
AU476761B2 (enExample)
AU465372B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
AU474593B2 (enExample)
AU474511B2 (enExample)
AU474838B2 (enExample)
AU465453B2 (enExample)
AU465434B2 (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AR201229Q (enExample)
AR199451A1 (enExample)
AU476696B2 (enExample)
AU472848B2 (enExample)
AU466283B2 (enExample)
AU477823B2 (enExample)
AR193950A1 (enExample)
AR196382A1 (enExample)
AU447540B2 (enExample)
AU477824B2 (enExample)
AR195948A1 (enExample)
AR210729A1 (enExample)
AU476873B1 (enExample)